medigraphic.com
SPANISH

Revista de Enfermedades no Transmisibles Finlay

ISSN 2221-2434 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 3

<< Back Next >>

Finlay 2014; 4 (3)

Insulin therapy in diabetic hyperglycemic emergencies

Machado RD, Licea PM
Full text How to cite this article

Language: Spanish
References: 30
Page: 150-157
PDF size: 136.79 Kb.


Key words:

diabetes mellitus type I, insulin, hyperglycemia, diabetic ketoacidosis, perglycemic hyperosmolar nonketotic coma.

ABSTRACT

Background: diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic state are two of the most serious metabolic emergencies in diabetic patients.
Objective: to identify the type of metabolic complications (diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic state) in order to analyze the patients’ outcome considering the plasma pH levels, as well as the mode of insulin administration.
Method: a cross-sectional descriptive study was conducted in 52 patients admitted to the intensive care unit of the Enrique Cabrera Hospital from 2000 to 2007. The variables analyzed included: type of diabetes mellitus, type of acute complication, mode of insulin administration, blood gas analysis and outcome.
Results: diabetic ketoacidosis occurred in 57.5 % of the type 1 diabetic patients and in the 42.5 % of the type 2 diabetics. None of the type 1 diabetics developed hyperglycemic hyperosmolar nonketotic state and this complication was observed in 23.0 % of the patients with diabetes type 2. Microdosing was the mode of insulin administration that predominated in both ketoacidosis and hyperglycemic state cases. Mortality was higher in the hyperglycemic state (67 %) and using microdoses in the insulin therapy.
Conclusions: diabetic ketoacidosis was the major complication. Mortality from diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic state was high and the mode of insulin administration was inadequate in some patients.


REFERENCES

  1. Wilson JF. Diabetic ketoacidosis. Ann Intern Med. 2010 ; 152 (1): 1-16.

  2. Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, et al. Hyperglycemic crises in patients with diabetes mellitus. Diabetes Care. 2003 ; 26 Suppl 1: SS109-S17.

  3. Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, et al. Hyperglycemic crises in diabetes. Diabetes Care. 2004 ; 27 Suppl 1: SS94-S102.

  4. Wallace TM, Matthews DR. Recent advances in the monitoring and management of diabetic ketoacidosis. QJM. 2004 ; 97 (12): 773-80.

  5. Van den Berghe G. Tight blood glucose control with insulin in “real-life” intensive. Care Mayo Clin Proc. 2004 ; 79 (8): 977-8.

  6. Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care. 2001 ; 24 (1): 131-53.

  7. Jolobe O. More fundamental issues in diabetic ketoacidosis. QJM. 2011 ; 104 (9): 820-1.

  8. Hernández EA, Castrillón JA, Acosta JG, Castrillón DF. Diabetes mellitus en el servicio de urgencias: manejo de las complicaciones agudas en adultos. Salud Barranquilla. 2008 ; 24 (2): 273-93.

  9. Machado D, Licea M. Uso del bicarbonato de sodio en las urgencias hiperglucémicas diabéticas. Finlay [revista en Internet]. 2013 [ cited 5 Ene 2014 ] ; 3 (3): [aprox. 7p]. Available from: http://www.revfinlay.sld.cu/index.php/finlay/articl e/view/164.

  10. Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low-dose insulin protocol for the treatment of diabetic ketoacidosis?. Diabetes Care. 2008 ; 31 (11): 2081-5.

  11. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. AJ Clin Pathol. 1969 Mar ; 22 (2): 158-61.

  12. Henry RJ, Cannon DC, Winkelman JW. Determinación de glucosa en sangre. Química clínica. Bases y Tácticas. 2da. ed. Barcelona: Ed. Jims; 1980.

  13. Blanco A, Muñíz GN, López J, Sentenac JG. Urgencias en el diabético. Hiperglucemia. Cetoacidosis diabética. Hiperosmolar. Hipoglucemia. In: Jiménez AJ. Manual de protocolos y actuación en urgencias [Internet]. 2da. ed. Toledo: FISCAM; 2004. [ cited 23 Mar 2013 ] Available from: http://www.slideshare.net/littmman/manual-de-pr otocolos-y-actuacin-en-urgencias#.

  14. Trachtenbarg DE. Diabetic Ketoacidosis. Am Fam Physician. 2005 ; 71 (9): 1705-14.

  15. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Diabet Med. 1998 ; 15 (7): 539-53.

  16. Nugent BW. Hiperosmolar Hyperglycemic State. Emerg Med Clin North Am. 2005 ; 23 (3): 629-48.

  17. Falciglia M, Freyberg RW, Almenoff PL, D´Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009 ; 37 (12): 3001-9.

  18. Chiasson JL, Aris-Jilwan N, Bélanger R, Bertrand S, Beauregard H, Ekoé JM, et al. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. CMAJ. 2003 ; 168 (7): 859-66.

  19. Castro SCJ, Cimé O, Pérez HS, González LMR. Características clínico-epidemiológicas de las complicaciones agudas de la diabetes mellitus. Med Int Mex. 2005 ; 21 (1): 259-65.

  20. Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2006 ; 29 (12): 2739-48.

  21. Vergel MA, Azkoul J, Meza M, Salas A, Velázquez EM; Grupo de Trabajo Unidad de Endocrinología Mérida-Venezuela. Cetoacidosis diabética en adultos y estado hiperglucémico hiperosmolar. Diagnóstico y tratamiento. Rev Venez Endocrinol Metab. 2012 ; 10 (3): 1-10.

  22. Nyenwe EA, Kitabchi A. Evidence based management of hyperglycemic emergencies in diabetes mellitus. Diabetes Res Clin Pract. 2011 ; 94 (3): 340-51.

  23. Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB. Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab. 2008 ; 93 (5): 1541-52.

  24. Kitbachi AE, Ayyagari V, Guerra SM. The efficacy of low-dose versus convencional therapy of insulin for treatment of diabetic ketoacidosis. Ann Intern Med. 1976 ; 84 (6): 633-8.

  25. Padilla AJ, Loeb JN. ¨Low dose¨ versus ¨high-dose¨ insulin regimens in the managements of uncontrolled diabetes: A survey. Am J Med. 1977 ; 63 (6): 843-8.

  26. Bracho F. Cetoacidosis diabética. MEDICRIT. 2005 ; 2 (1): 9-16.

  27. Umpierrez GE, Cuervo R, Karabell A, Latif K, Freire AX, Kitabchi AE. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care. 2004 ; 27 (8): 1873-78.

  28. Umpierrez GE, Latif K, Stoever J, Cuervo R, Park L, Freire A, et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.. Am J Med. 2004 ; 117 (5): 291-6.

  29. Finfer S, Chittock DR, Su SY, Blair D, Foster D; Nice-Sugar Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 ; 360 (13): 1283-97.

  30. Umpierrez GE, Jones S, Smiley D, Mulligan P, Keyler T, Temponi A, et al. Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial. Diabetes Care. 2009 ; 32 (7): 1164-9.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Finlay. 2014;4